Fuse Group terminates E-Mo Biotech acquisition; restates Q1, Q2 2021 financials

FUSE GROUP HOLDING INC.

Terminated Share Exchange Agreement to acquire E-Mo Biotech; no shares issued or exchanged.
Will restate financials for quarters ended March 31 and June 30, 2021 due to reclassification error.
14,285,715 shares issued as prepayment for mining rights reclassified to equity deduction per SAB Topic 4:E.
Non-reliance on previously issued Q1 and Q2 2021 financial statements; amendment to 10-Qs planned.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.